Kenji Harada

7PUBLICATIONS
22CO-AUTHORS
Natural language processingMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 23, 2025
Label Noise in Pathological Segmentation Is Overlooked, Leading to Potential Overestimation of Artificial Intelligence.

Kenji Harada, Yuichiro Nomura, Daisuke Komura

|Feb 21, 2025
PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer.

Kenji Harada, Naoya Sakamoto, Takumi Kitaoka

|Nov 22, 2021
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy.

Daiki Taniyama, Naoya Sakamoto, Tsuyoshi Takashima

|Jun 08, 2021
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.

Quoc Thang Pham, Daiki Taniyama, Shintaro Akabane

|Mar 31, 2021
Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.

Tsuyoshi Takashima, Daiki Taniyama, Naoya Sakamoto

|Jan 10, 2021
KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.

Shoichi Ukai, Naoya Sakamoto, Daiki Taniyama

Pageof 2

Frequent Collaborators

5 joint publications

Wataru Yasui

4 joint publications

Quoc Thang Pham

4 joint publications

Naoya Sakamoto

3 joint publications

Shoichi Ukai